Table:
begin	end	state
1	11	cytoplasmic
12	33	transmembrane
34	38	non-cytoplasmic
39	59	transmembrane
60	65	cytoplasmic
66	85	transmembrane
86	90	non-cytoplasmic
91	111	transmembrane
112	117	cytoplasmic
118	137	transmembrane
138	164	non-cytoplasmic
165	184	transmembrane
185	213	cytoplasmic
214	235	transmembrane
236	247	non-cytoplasmic
248	276	transmembrane
277	287	cytoplasmic
288	310	transmembrane
311	338	non-cytoplasmic

Input:
>WP_045585627.1 NCBI__GCF_001305595.1:WP_045585627.1
MSTHSHGRPLAQPFAIGGGVAALAVLPFLAGNAYLEHLLVLWMLYALLALSLNIVIGYLG
ELTFGHAAFVGVGAYTSAILSTQLGLPPLLGLPMAGLVAAMFGLVIGYAALRVVGPQFAI
LTLGFGAILFTITNHWVDLTRGPMGISDIPPMAVGPLTFTAARETYYLVLVLVLATAYLC
HALVSSRTGRAFLAVRENAPLAASLGINVFHTKLLGFVAATAIAGIGGAIYAHYIRVITP
DIMGVHNVAALIIVVIIGGRGTILGPILGALVYIGLLESLRVAGPLRMVIFAALLTGTVV
FLPGGLVSLWQRWRNSHKAENNLPAAANGLPSTEGGAK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server